Originator and biosimilar market dynamics

Godman, Brian (2021) Originator and biosimilar market dynamics. In: Biosimilars Latam - Brazil 2021, 2021-08-25 - 2021-08-26, Online Event.

[thumbnail of Godman-LATAM-2021-Originator-and-biosimilar-market]
Preview
Text (Godman-LATAM-2021-Originator-and-biosimilar-market)
Godman_LATAM_2021_Originator_and_biosimilar_market.pdf
Final Published Version

Download (1MB)| Preview
    [thumbnail of Biosimilars-Latam-Brazil-2021-overview]
    Preview
    Text (Biosimilars-Latam-Brazil-2021-overview)
    Biosimilars_Latam_Brazil_2021_overview.pdf
    Final Published Version

    Download (3MB)| Preview

      Abstract

      There is growing expenditure on medicines worldwide, estimated to reach US$1.5 trillion by 2023, with implications for affordability even in high income countries. This increase is driven by biological medicines for complex diseases, including cancer and orphan diseases , which are becoming unaffordable. The costs even for the anti TNFs has resulted in their limited prescribing among a number of Central and Eastern European countries, which is difficult to sustain. Biosimilars offer a way forward to improve the care of patients with proven similar effectiveness and safety between originators and biosimilars, e.g. NOR SWITCH study in Norway.